timolol ophthalmic
Selected indexed studies
- Metabolism of ophthalmic timolol: new aspects of an old drug. (Basic Clin Pharmacol Toxicol, 2011) [PMID:21385322]
- Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study. (PLoS One, 2022) [PMID:36454807]
- Paroxetine markedly increases plasma concentrations of ophthalmic timolol; CYP2D6 inhibitors may increase the risk of cardiovascular adverse effects of 0.5% timolol eye drops. (Drug Metab Dispos, 2014) [PMID:25261563]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study. (2022) pubmed
- Metabolism of ophthalmic timolol: new aspects of an old drug. (2011) pubmed
- Paroxetine markedly increases plasma concentrations of ophthalmic timolol; CYP2D6 inhibitors may increase the risk of cardiovascular adverse effects of 0.5% timolol eye drops. (2014) pubmed
- Nightclub Photokeratitis. (2020) pubmed
- Timolol and cornea. (1986) pubmed
- Absorption of ocular timolol. (1980) pubmed
- The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes. (2015) pubmed
- Self-Assembling Elastin-Like Hydrogels for Timolol Delivery: Development of an Ophthalmic Formulation Against Glaucoma. (2017) pubmed
- Ophthalmic timolol in a hydrogel vehicle leads to minor inter-individual variation in timolol concentration in aqueous humor. (2009) pubmed
- Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. (2005) pubmed